Cargando…
Fragment-Based Screening of the Bromodomain of ATAD2
[Image: see text] Cellular and genetic evidence suggest that inhibition of ATAD2 could be a useful strategy to treat several types of cancer. To discover small-molecule inhibitors of the bromodomain of ATAD2, we used a fragment-based approach. Fragment hits were identified using NMR spectroscopy, an...
Autores principales: | Harner, Mary J., Chauder, Brian A., Phan, Jason, Fesik, Stephen W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255743/ https://www.ncbi.nlm.nih.gov/pubmed/25314628 http://dx.doi.org/10.1021/jm501035j |
Ejemplares similares
-
Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
por: Evans, Chiara M., et al.
Publicado: (2021) -
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
por: Miller, Duncan C., et al.
Publicado: (2018) -
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
por: Yao, Dahong, et al.
Publicado: (2020) -
Targeting Low-Druggability
Bromodomains: Fragment
Based Screening and Inhibitor Design against the BAZ2B Bromodomain
por: Ferguson, Fleur M., et al.
Publicado: (2013) -
Mapping Ligand
Interactions of Bromodomains BRD4 and
ATAD2 with FragLites and PepLites—Halogenated Probes of Druglike
and Peptide-like Molecular Interactions
por: Davison, Gemma, et al.
Publicado: (2022)